Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission
– Pure-Vu Gastro achieves high usability scores in supporting upper endoscopy procedures with first time…
News
Motus GI Completes First Clinical Evaluation of New Pure-Vu® Gastro in Upper Gastrointestinal (GI) Procedures to Support FDA Submission
– Pure-Vu Gastro achieves high usability scores in supporting upper endoscopy procedures with first time…
Shockwave Appoints Kevin Ballinger to Board of Directors
SANTA CLARA, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
Shockwave Appoints Kevin Ballinger to Board of Directors
SANTA CLARA, Calif., May 17, 2023 (GLOBE NEWSWIRE) — Shockwave Medical, Inc. (Nasdaq: SWAV), a…
ORYZON to Present Trial in Progress Phase Ib FRIDA Study at the Upcoming 2023 ASCO Annual Meeting
MADRID, Spain and BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code:…
ORYZON to Present Trial in Progress Phase Ib FRIDA Study at the Upcoming 2023 ASCO Annual Meeting
MADRID, Spain and BOSTON, May 17, 2023 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code:…
Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer
Media Release Immuno-oncology combination of eftilagimod alpha (efti) and the leading anti-PD-1 therapy generates meaningful…
Immutep’s Efti in Combination with Pembrolizumab Achieves Excellent Initial Overall Survival Benefit in 1st Line Non-Small Cell Lung Cancer
Media Release Immuno-oncology combination of eftilagimod alpha (efti) and the leading anti-PD-1 therapy generates meaningful…
Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank
Refinanced Loan Extends Maturity to December 2024 SEATTLE and VANCOUVER, British Columbia, May 17, 2023…
Achieve Life Sciences Announces Refinancing of Outstanding Loan with Silicon Valley Bank
Refinanced Loan Extends Maturity to December 2024 SEATTLE and VANCOUVER, British Columbia, May 17, 2023…
Mendus secures third shareholder loan from Van Herk Investments
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
Mendus secures third shareholder loan from Van Herk Investments
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today…
IN8bio’s DeltEx Gamma-Delta T Cells Show Promise in Targeting Ovarian Cancer
Preclinical results showcase the potential for the strong synergistic combination of chemotherapy and gamma-delta T…
IN8bio’s DeltEx Gamma-Delta T Cells Show Promise in Targeting Ovarian Cancer
Preclinical results showcase the potential for the strong synergistic combination of chemotherapy and gamma-delta T…
Ardelyx Announces FDA Acceptance and Six-Month Review for Resubmission of its New Drug Application of XPHOZAH® (tenapanor)
User Fee Goal Date: October 17, 2023 WALTHAM, Mass., May 17, 2023 (GLOBE NEWSWIRE) —…
Ardelyx Announces FDA Acceptance and Six-Month Review for Resubmission of its New Drug Application of XPHOZAH® (tenapanor)
User Fee Goal Date: October 17, 2023 WALTHAM, Mass., May 17, 2023 (GLOBE NEWSWIRE) —…
Verizon upgrades network for Tampa customers
Recent upgrades lead to testing results that show customers have the best experience on the…
Verizon upgrades network for Tampa customers
Recent upgrades lead to testing results that show customers have the best experience on the…
Verizon lights up 5G Ultra Wideband across Pennsylvania
Customers across Pennsylvania benefit from new high-performance 5G technology with higher speeds, greater capacity and…
Verizon lights up 5G Ultra Wideband across Pennsylvania
Customers across Pennsylvania benefit from new high-performance 5G technology with higher speeds, greater capacity and…